Impossible Closes $300 million funding round

Categories Newsworthy

Beyond Meat (NASDAQ:BYND) competitor, Impossible Foods, just completed a $300 million funding round putting the company at a $2 billion valuation. Impossible Burgers are different from Beyond Burger because they incorporate cellular technology to synthesize an ingredient called heme. Heme is arguably what makes the Impossible Burger taste more “meaty” than the Beyond Burger, giving Impossible a slight edge in the uniqueness of their offering.

  • Institutional investors include Khosla Ventures, Microsoft Corp co-founder Bill Gates, Google Ventures, Horizons Ventures, UBS, Viking Global Investors, Temasek, Sailing Capital, and Open Philanthropy Project.
  • The company has now raised more than $750M and is valued at more than $2B.
  • Impossible Burger is sold at more than 7,000 restaurants and plans to roll out at Burger King nationwide this year.
  • Impossible Burger’s are currently not sold at any retailers, but sources say a retail roll out can be expected this year.

Why We Care: Impossible Foods is proving that demand for alternative protein is high if the right branding and flavors are incorporated. Impossible Foods heme ingredient is both bio-engineered and made using cellular fermentation.